BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04214067-completion@plaintrial.com
DTSTAMP:20261027T081955Z
DTSTART;VALUE=DATE:20270205
SUMMARY:Testing the Addition of the Immunotherapy Drug\, Pembrolizumab\, to
  the Usual Radiation Treatment for Newly Diagnosed Early Stage High Interm
 ediate Risk Endometrial Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04214067
URL:https://plaintrial.com/trial/NCT04214067
END:VEVENT
END:VCALENDAR
